In the media

<p>ICREA researcher at IRB Barcelona, Núria López-Bigas</p>
23 Dec 2019 -

The newspaper La Vanguardia has reported on the award of the “Doctores Diz Pintado” National Cancer Research Prize, to  Núria López-Bigas ICREA researcher at the Institute for Research in Biomedicine (IRB Barcelona)  in recognition of her work on the accumulation of mutations in the genome. Referring to López-Bigas, the jury highlighted "the relevance and impact of her work, which focuses on genomics and has wide applications in personalised medicine."

Link to: La Vanguardia 


<p>Modesto Orozco, head of the Molecular Modelling and Bioinformatics Lab at IRB Barcelona</p>
19 Dec 2019 -

Nostrum Biodiscovery, a company founded by Modesto Orozco, head of the Molecular Modelling and Bioinformatics Lab at IRB Barcelona, features in an article published by Expansión and devoted to the Botín Foundation’s "Mind the Gap" Programme.

<p>Roger Gomis, head of the Growth Control and Metastasis Laboratory, IRB Barcelona.</p>
29 Nov 2019 -

The newspaper ABC has reported on a new project to be launched by IRB Barcelona researcher Roger Gomis thanks to a grant from the Fundación Fero y Mango. Focusing on luminal breast cancer, one of the most common subtypes, the project aims to decipher the “dialogue” between tumour cells and bone stem cells. This information can then be used to design therapeutic targets and to limit the capacity of these cells to metastasize. “This is a groundbreaking approach to tackle metastasis in this kind of cancer,” says Gomis.

Beside, La Razón has reported on this project. In its article “Visionarios contra el cáncer”, it highlights that 15% of women with this type of tumour experience...

<p>Meritxell Teixidó, IRB Barcelona</p>
27 Nov 2019 -

In its “Preguntas Big Van” section, the newspaper La Vanguardia has interviewed IRB Barcelona researcher Meritxell Teixidó about her project, which seeks to develop “shuttles” that transport drugs into the brain. In this regard, 98% of drugs that start to be developed to treat diseases of the central nervous system are abandoned because they cannot cross the barrier that protects the brain. Inspired on bee and scorpion venom, Teixidó has identified several families of peptides capable of crossing this barrier. The research has been possible thanks to the funding of a CaixaImpulse project from the ”la Caixa” Foundation and a project awarded through the La Fundació La Marató de TV3.

<p>Manuel Serrano, ICREA researcher at IRB Barcelona, during his talk at the Barcelona Biomed Conference.</p>
27 Nov 2019 -

The newspapers El País and ABC, among other media, have echoed on the last Barcelona Biomed Conference, called “Immunotherapy beyond cancer. A cure for age-related diseases”, which was held from 18 to 20 November.  “Immunotherapy is still very experimental, but we believe that in the future it could be beneficial for the treatment of diseases such as Alzheimer’s, Parkinson’s and pulmonary and renal fibrosis,” says Manuel Serrano, ICREA researcher at IRB Barcelona and co-organiser of the conference together with the scientist Guido Kroemer, from the Centre de Recherche des Cordeliers (Paris). As in previous events, this conference was organised by IRB Barcelona with the support of the...

<p>Erika Lopez, IRB Barcelona.</p>
25 Nov 2019 -

The newspaper La Tribuna de Albacete has interviewed IRB Barcelona researcher Erika López Arribillaga about a grant awarded to her on 24 September by the Spanish Association Against Cancer (AECC). López Arribillaga’s project aims to unravel the long-term effects of some chemotherapy treatments on colorectal cancer patients. 


Link to La Tribuna de Albacete



<p>Researchers at IRB Barcelona have identified these genetic footprints produced by some cancer treatments and have for the first time been able to calculate the genetic toxicity of some of these treatments. Claudia Arnedo, IRB Barcelona.</p>
25 Nov 2019 -

The newspapers El Mundo, La Vanguardia and Diari Ara, the TV station TV3 and the radio stationsCatalunya Ràdio andRAC1, among other media, have echoed on a study by the Biomedical Genommics lab, headed by Núria López, published in Nature Genetics. The study has for the first time determined the genetic mutations caused by various therapies used to treat cancer. “Studying the DNA damage caused by chemotherapies in patients’ cells is the first step towards understanding the relation between these mutations and the long-term side effects of these treatments,” says Oriol Pich, PhD student at IRB Barcelona and first author of the article.





Link to...

<p>Predictive decision trees optimized to decide if a cancer mutation will become visible to the immune system. Rik G.H. Lindeboom, Radboud University.</p>
25 Nov 2019 -

RTVE, the newspaper Heraldo de Aragón, and Diario Médico—the newspaper specialized in health—among other media, have echoed on a new algorithm, developed by researchers at IRB Barcelona in collaboration with the Centre for Genomic Regulation and the University of Radboud, that allows identification of those patients who are most likely to benefit from immunotherapy. Based on machine learning, the scientists have developed a tool that detects the genetic mutations that activate the immune system. This algorithm also identifies those people with certain hereditary diseases that would benefit from certain kinds of drug already on the market. The study was published in the journal Nature...

<p>Salvador Aznar Beniath, IRB Barcelona</p>
15 Nov 2019 -

The newspaper ABC, among other media, have reported on the “Premio Carmen y Severo Ochoa de Investigación en Biología Molecular 2019", which has been given to IRB Barcelona researcher Salvador Aznar Benitah. “This recognition is particularly special because it is the Carmen and Severo Ochoa Prize; you only have to take a look at the list of former awardees, all of them with an incredible career and who do first-rate science. It´s an honour for me to join this group,” said the researcher after being presented with the prize. 



<p>Carme Cortina, researcher at IRB Barcelona</p>
7 Nov 2019 -

“Cinc dies a...” broadcasted by La2 has devoted a programme to the day to day lives of all those who work at the Barcelona Science Park, ranging from researchers to admin staff and other service staff. Several members of the IRB Barcelona community participated in the programme. Lara Barrio, a researcher with the Growth Control and Development Lab, showed how studying the vinegar fly Drosophila can help us to understand human diseases. In the Colorectal Cancer Lab, the scientists Elena Sancho and Carme Cortina explained their research into colon cancer and metastasis. In addition, Silvia Frutos, Alumna of IRB Barcelona, commented on how she founded her company ProteoDesign seven years...